Skip to main content
SpringerLink
Log in

Nephrotoxicity of cisplatin, carboplatin and transplatin

A comparative in vitro study

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The present study was designed to compare the nephrotoxicity induced by the three platinum compounds cisplatin (CDDP), carboplatin (CBDCA) and transplatin (TDDP) in vitro and to obtain information to elucidate the mechanism of platinum compound-induced nephrotoxicity. Rat or rabbit renal cortical slices were incubated for different periods of time in platinum compound-containing media (0.42 or 1.67 mM) and thereafter monitored for platinum content, tetraethylammonium(TEA) and paraaminohippurate(PAH) accumulation and gluconeogenesis. Malondialdehyde(MDA) content of slices was determined as a parameter of lipid peroxidation. Activity of glucose-6-phosphatase of rat renal microsomes was investigated after platinum-compound exposure. In all series of experiments the effect of the antioxidant N,N′diphenyl-p-phenylenediamine (DPPD) was tested. CBDCA showed no effects on all parameters of renal cell function at all concentrations and all time points investigated, except for the activity of glucose-6-phosphatase, which was slightly affected by CBDCA. CBDCA-induced MDA production was lower, compared to CDDP, which showed marked toxic effects on TEA and PAH accumulation, gluconeogenesis and glucose-6-phosphatase activity. The onset of CDDP-induced alterations was dependent on drug concentration. MDA production was reduced by DPPD. Protection against the platinum compound-induced decrease in TEA and PAH accumulation was observed after the use of DPPD. DPPD had no protective effect on CDDP-induced inhibition of gluconeogenesis and glucose-6-phosphatase, which might indicate an effect on gluconeogenesis by direct inhibition of glucose-6-phosphatase. DPPD did not alter uptake of platinum compounds in rat renal cortical slices. TDDP showed different in vitro properties compared to in vivo conditions. In conclusion, association of CDDP-induced nephrotoxicity with lipid peroxidation was shown. CBDCA induced less generation of lipid peroxidation products and only very small nephrotoxic effects. Antioxidants may restrict CDDP-induced alterations in renal cell function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P (1988) Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. Eur J Cancer Clin Oncol 24: 1471–1479

    Article  PubMed  Google Scholar 

  • Baginski ES, Foa PP, Zak B (1974) Glucose-6-phosphatase. In: Bergmeyer HU (ed) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim/Bergstr., pp 909–913

    Google Scholar 

  • Bielack SS, Entmann R, Looft G, Purfürst C, Delling G, Winkler K, Landbeck G (1989) Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cancer Chemother Pharmacol 24: 376–380

    Article  PubMed  Google Scholar 

  • Bird JE, Walser MM, Quebbemann AJ (1984) Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity. J Pharmacol Exp Ther 231: 752–758

    PubMed  Google Scholar 

  • Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302–310

    PubMed  Google Scholar 

  • Cojocel C, Hannemann J, Baumann K (1985) Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity. Biochim Biophys Acta 834: 402–410

    PubMed  Google Scholar 

  • Cojocel C, Göttsche U, Tölle KL, Baumann K (1988) Nephrotoxic potential of first-, second-, and third-generation cephalosporins. Arch Toxicol 62: 458–464

    Article  PubMed  Google Scholar 

  • Choie DD, Longnecker DS, del Campo AA (1981) Acute and chronic cisplatin nephropathy in rats. Lab Invest 44: 397–402

    PubMed  Google Scholar 

  • Cross RJ, Taggart JV (1950) Renal tubular transport: accumulation of p-aminohippurate by rabbit kidney slices. Am J Physiol 161: 181–190

    PubMed  Google Scholar 

  • Damiani E, Cattaneo MT, Sessa C, Zucca E, Cavalli F, Bertolini A, Libretti A, Beretta R (1987) Enzymuria in carboplatin nephrotoxicity. Tumori 73: 487–491

    PubMed  Google Scholar 

  • Ernster L, Nordenbrand K, Orrenius S (1982) Microsomal lipid peroxidation: mechanism and some biomedical implications. In: Yagi K (ed) Lipid peroxides in biology and medicine. Academic Press Inc., New York, pp 55–79

    Google Scholar 

  • Friedmann ME, Teggins JE (1974) The reactivities of isomers of dichlorodiammine-platinum(II) with dehydrogenase enzymes: evidence for inhibition via cross-linkage. Biochim Biophys Acta 350: 263–272

    PubMed  Google Scholar 

  • Gemba M, Fukuishi N, Nakano S (1988) Effect of N-N′-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats. Jpn J Pharmacol 46: 90–92

    PubMed  Google Scholar 

  • Goldstein RS, Noordewier B, Bond JT, Hook JB, Mayor GH (1981) Cis-dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol Appl Pharmacol 60: 163–175

    Article  PubMed  Google Scholar 

  • Hannemann J, Baumann K (1988a) Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51: 119–132

    Article  PubMed  Google Scholar 

  • Hannemann J, Baumann K (1988b) Inhibition of lactate dehydrogenase by cisplatin and other platinum compounds: enzyme leakage of LDH is not a suitable method to measure platinum compound-induced kidney cell damage in vitro. Res Commun Chem Pathol Pharmacol 60: 371–379

    PubMed  Google Scholar 

  • Hannemann J, Baumann K (1988c) Effect of carboplatin and cisplatin on uptake of p-aminohippurate (PAH) or tetraethylammonium (TEA), and on lipid peroxidation in rat renal cortical slices. International Symposium on Prevention, Treatment and Diagnosis of Acute Renal Failure: From the Laboratory to the Clinic, Edmonton Alberta, Canada (Abstract)

    Google Scholar 

  • Hannemann J, Baumann K (1989) Lipid peroxidation as a mechanism of cisplatin-induced nephrotoxicity. In: Bach PH, Lock EA (eds) Nephrotoxicity: extrapolation from in vitro to in vivo, and animals to man. Plenum Press, London, pp 343–348

    Google Scholar 

  • Hannemann J, Duwe J, Baumann K (1990) Lipid peroxidation in renal microsomes of cisplatin (CP)-treated rats. In: Bach PH, Lock EA (eds) Mechanisms of nephrotoxicity: the basis for early diagnosis. Modulation of effects and improved therapeutic management. Marcel Dekker, New York (in press)

    Google Scholar 

  • Hoeschele JD, VanCamp L (1972) Whole-body counting and the distribution of cis195mPt (NH3)2Cl2) in the major organs of swiss white mice. Adv Antimicrob Antineoplast Chemother 2: 241–242

    Google Scholar 

  • Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A (1971) Antileukaemic and nephrotoxic properties of platinum compounds. Nature 234: 43–45

    PubMed  Google Scholar 

  • Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin. Ann Intern Med 100: 704–713

    Google Scholar 

  • Nelson JA, Santos G, Herbert BH (1984) Mechanisms for the renal secretion of cisplatin. Cancer Treat Rep 68: 849–853

    PubMed  Google Scholar 

  • Phelps JS, Gandolfi AJ, Brendel K, Dorr RT (1987) Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol 90: 501–512

    Article  PubMed  Google Scholar 

  • Quanguan J, Moldéus P (1988) Effect of the antioxidant N,N′-diphenylp-phenylenediamine (DPPD) on bromobenzene metabolism and toxicity in isolated hepatocytes, Pharmacol Toxicol 62: 104–106

    PubMed  Google Scholar 

  • Reed E, Jacob J (1989) Carboplatin and renal dysfunction. Ann Intern Med 110: 409

    Google Scholar 

  • Roobol A, Alleyne GAO (1974) Control of renal cortex ammoniagenesis and its relationship to renal cortex gluconeogenesis. Biochim Biophys Acta 362: 83–91

    PubMed  Google Scholar 

  • Safirstein R, Miller P, Guttenplan JB (1984) Uptake and metabolism of cisplatin by rat kidney. Kidney Int 25: 753–758

    PubMed  Google Scholar 

  • Safirstein R, Winston J, Moel D, Dikman S, Guttenplan J (1987) Cisplatin nephrotoxicity: insights into mechanism. Int J Androl 10: 325–346

    PubMed  Google Scholar 

  • Schacterle GR, Pollack RL (1973) A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 51: 654–655

    Article  PubMed  Google Scholar 

  • Sedgwick B, Hübscher G (1965) Metabolism of phospholipids. IX. Phosphatidate phosphohydrolase in rat liver. Biochim Biophys Acta 106: 63–77

    PubMed  Google Scholar 

  • Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 25: 388–404

    Google Scholar 

  • Smith IE, Harland SJ, Robinson BA, Evans BD, Goodhart LC, Calvert AH, Yarnold J, Glees JP, Baker J, Ford HT (1985) Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep 69: 43–46

    PubMed  Google Scholar 

  • Smith JH, Smith MA, Litterst CL, Copley MP, Uozumi J, Boyd MR (1988a) Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the fischer 344 rat. Fundam Appl Toxicol 10: 45–61

    Article  PubMed  Google Scholar 

  • Smith JH (1988b) The use of renal cortical slices from the fischer 344 rat as an in vitro model to evaluate nephrotoxicity. Fundam Appl Toxicol 11: 132–142

    Article  PubMed  Google Scholar 

  • Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M (1987a) Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 43: 247–252

    PubMed  Google Scholar 

  • Sugihara K, Nakano S, Gemba M (1987b) Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 44: 71–76

    PubMed  Google Scholar 

  • Sugiyama S, Hayakawa M, Kato T, Hanaki Y, Shimizu K, Ozawa T (1989) Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun 159: 1121–1127

    Article  PubMed  Google Scholar 

  • Wile AG, Kar R, Cohen RA, Jakowatz JG, Opfell RW (1987) The pharmacokinetics of cisplatin in experimental regional chemotherapy. Cancer 59: 695–700

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Physiology, Institute of Physiology, University of Hamburg, Grindelallee 117, D-2000, Hamburg 13, Federal Republic of Germany

    Jörg Hannemann & Karl Baumann

Authors
  1. Jörg Hannemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hannemann, J., Baumann, K. Nephrotoxicity of cisplatin, carboplatin and transplatin. Arch Toxicol 64, 393–400 (1990). https://doi.org/10.1007/BF01973462

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01973462

Key words

Search

Navigation